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Although unusual for its sacrilegious
image of a nun lifting her eyes towards
the “heavenly” Antikamnia tablet, this
1898 large format (5” x 8”) trading card
is typical of the formula that combined
collectable pictures with printed product
information on the verso. Tracing their
origins from seventeenth-century London
trade cards, trading cards evolved
into our modern business cards. Trade
cards, in the original sense of the word,
referred to cards distributed by business
proprietors to announce their trade or
line of work. With the development of
inexpensive color printing in the late
nineteenth century, collecting and trading
of these attractive cards became a
popular hobby. (Collection of the author)

The ailments that could be treated with one or two Antikamnia tablets
ranged from toothache to Le Grippe (today, the flu) as well as “severe
headaches, especially those of lawyers, students, bookkeepers, clerks,
mothers, saleswomen, teachers, and nurses.” The tablets were also
recommended as a preventative “before starting on an outing, and
this includes tourists, picnickers, bicyclers, and in fact, anybody who
is out in the sun and air all day, will entirely prevent that demoralizing
headache which frequently mars the pleasure of such an occasion” or
for “women on shopping tours.” (Collection of the author)
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With palpable pain etched into
her face and the enfolding wings
of a powerful drug shielding the
victim from the satanic serpent of
her affliction, an 1899 Art Nouveau
advertisement mailed to British
physicians promoted the Antikamnia
Chemical Company of St. Louis.
Besides generating tremendous
wealth, which allowed Frank A. Ruf
an international reputation as an art
collector, Antikamnia tablets and its
advertising cards defined the power
of the newly created Food and Drug
Administration.
In the late 1880s, Louis E. Frost, a
graduate of the St. Louis College of
Pharmacy, and Frank A. Ruf, who had
studied business at St. Benedict’s College,
met as drug store clerks and subsequently
opened their own drug store. No evidence
exists that either was ever a licensed
pharmacist. After hitting upon a successful
formula, they incorporated the Antikamnia
Chemical Company to manufacture their
analgesic, which combatted pain and
incorporated antipyretic powder to reduce
fever. The name, taken from two Greek
words that combined to mean “opposed to
pain,” was trademarked in 1890. Financial
reverses in other business ventures forced
Frost to sell his Antikamnia shares in
1892. Combining a winning formula and
good business instincts, Ruf continued the
company with another partner. By 1894, the
firm began using the monogrammed
letters “AK” in its advertising and
pressed them onto its tablets. Although

Antikamnia tablets did not require a
prescription, the company sold primarily
to drug stores rather than to individuals.
Most of its advertising, such as the cards
illustrated here, was directed towards
physicians, encouraging them to prescribe
and recommend the tablets to their patients.
While the precise formula varied over
time, the principle active ingredients in
Antikamnia tablets remained the coaltar derivative acetanilid combined with
caffeine, sodium bicarbonate, and citric
acid. Two German chemists discovered
acetanilid in 1886. When testing its capacity
for reducing pain and fever, they noted the
side effect of cyanosis, a turning blue in the
extremities from a lack of oxygen caused
by depressed respiration and heart rate.
Acetanilid was a legitimate pharmaceutical,
listed in the National Formulary until
1955. However, it could be deadly when
used carelessly; the first acetanilid-related
deaths were reported in 1891. Antikamnia
tablets were also formulated in combination
with codeine, heroin, quinine, salol, and
laxatives.
Because of the deaths associated with
this drug, Antikamnia was one of the
patent medicines particularly targeted by
progressive consumer advocate Harvey W.
Wiley, the first commissioner of the newly
created Food and Drug Administration.
The term “patent medicine” is somewhat
of a misnomer, because few, if any, of the
medicinal remedies marketed before the
advent of the 1906 Pure Food and Drug
laws were actually patented. Application
for a patent would require, among other
things, that manufacturers reveal the exact
contents of their medicines and prove their
claimed benefits. After the Food and Drug
Administration ruled in 1907 that

The Antikamnia Company directed a large percentage of its
advertising budget into direct mailings, such as this postal card
to physicians and pharmacists, providing them with free samples
and literature to gain their acceptance and prescriptions.
(Collection of the author)

preparations containing acetanilid must
be clearly labeled, the Antikamnia
Company changed its formula
for the domestic market, instead using
acetaphenetidin, an acetanilid derivative. It
then advertised that its product contained
no acetanilid. However, the British market,
still unregulated, continued to receive the
original formula tablets. In 1910, U.S.
marshals seized a shipment of tablets for
being incorrectly labeled in violation of the
Pure Food and Drug Act. The ensuing court
case went all the way to the Supreme Court
which ruled on January 5, 1914 (U.S. v.
Antikamnia Chemical Company, 231 U.S.
654) that the Antikamnia Company had
indeed violated the Pure Food and Drug
Act both by not stating on its packaging
that acetaphenetidin was a derivative of
acetanilid and by the misleading advertising
that the tablets contained no acetanilid.
Beyond the impact on the Antikamnia
Company, this ruling was a landmark
in support of Progressive Era reform
legislation because it confirmed that federal
agencies, charged with the enforcement of
an Act, had the administrative authority to
make additional related regulations.
The markup on Antikamnia tablets,
which sold at roughly ten times the cost
of production, allowed Ruf to indulge his
passion for Persian art, particularly rugs.
When the quality of his rug collection
came to the attention of the Shah of Persia,
Ruf was awarded the fifth class star of
the Imperial Order of the Lion and Sun in
1908. At his death in 1923, Ruf’s estate was
valued at $2.5 million.

This “Dear Doctor” postal card with another graphic image of
women in pain announces that a copy of the “Antikamnia Fœtal
Chart and Parturition Calendar” has been mailed gratis. Not
unlike today, physicians received perks from the Antikamnia
Company; in this case, a fetal chart and calendar on labor and
delivery prepared by a well known medical illustrator. It is a
small wonder that this card was not barred from the mail under
the provisions of the Comstock Act (U.S. 17 Stat. 598) that
prohibited mailing “lewd, or lascivious” materials.
(Collection of the author)
Fall 2009 | The Confluence | 21

